Adjunctive cariprazine for the treatment of major depressive disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2024.10.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von L Citrome und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA. Electronic address: nntman@gmail.com. Hauptthemen laut MEDLINE: Major Depressive Disorder, Piperazines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA. Electronic address: nntman@gmail.com.
- AbbVie, Florham Park, NJ, USA.
Förderung
- AbbVie Inc
Zitieren
APA
Citrome, L., Reda, I., & Kerolous, M. (2025). Adjunctive cariprazine for the treatment of major depressive disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.10.040
Vancouver
Citrome L, Reda I, Kerolous M. Adjunctive cariprazine for the treatment of major depressive disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2024.10.040
BibTeX
@article{Citrome2025,
author = {Citrome, L and Reda, I and Kerolous, M},
title = {Adjunctive cariprazine for the treatment of major depressive disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2024.10.040}
}
EUVIMED